arrow
M

Min-Suk Yang

university of california san diego
H指数:28
被引数:2,476

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model

1-甲基烟酰胺循环水平预测Dupilumab对成人哮喘的疗效:一项预测模型

2026-05-060
PRE
Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma
2025-12-010
PRE
Reply to “Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time”

回复“嗜酸性哮喘研究中优化FeNO和血嗜酸性粒细胞分层:调整吸烟史和采血时间”

2025-11-150
PRE
Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study
2025-11-011
PRE
Clinical characteristics and risk factors for escalation to anaphylaxis from non-severe drug hypersensitivity reaction

非严重药物超敏反应升级为过敏性休克的临床特征及危险因素

2025-04-220
OAAI
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study

重度哮喘中嗜酸性粒细胞和FeNO作为生物疗法的指标:来自“重度哮喘中的精准医学干预研究”的结果

2025-03-180
PRE
Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma

血清和尿液中嗜酸性粒细胞衍生神经毒素(EDN)水平可预测重度哮喘的生物制剂治疗反应

2025-01-010
PRE
Association of HLA-B*73:07 with DRESS and HLA-A*37:07 with eosinophilia in SJS/TEN induced by carbamazepine
2024-12-011
PRE
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment

2型生物制剂治疗重度嗜酸性粒细胞哮喘的纵向多轨迹表型

2024-12-010
OAAI
Gut permeability and its correlation with patient's traits and blood inflammatory markers in severe asthma: Real-world assessment from the Korean severe asthma registry-2 (KoSAR-2)
2024-11-080
PRE
Effect of biologic therapies on quality of life in severe asthma Findings from the PRISM study
2024-09-010
OAAI
Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR

生物制剂在严重哮喘患者中的真实效果: 对KoSAR的分析

2024-01-015
OAAI
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study

哮喘-COPD重叠和单纯哮喘患者对生物制剂治疗反应的比较: PRISM研究的结果

2023-12-014
OAAI
Skin Test-Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative Study
2023-11-015
PRE